We have heard about a licensing deal and a NASDAQ listing as two things high on Don's agenda. To get a NASDAQ listing - as far as I have researched the topic - they need a bid price of 4 USD/share. They are nowhere near at present. However, the market cap of Resverlogix is large enough for a NASDAQ listing, so one possibility would be a reverse split (which is a non-issue in my mind). Another possibility would be to have a deal with BP and make the analysts (the two new ones that DM referred to) rave about the importance of such a deal, leading to multi-dollar pps targets. Alternatively, if Zenith signs a deal - something I think is more likely than Resverlogix striking one - this may also shine a positive light on RVX. A Zenith deal would not be enough for a 4 USD bid, but together with a modest reverse split, it would be enough to qualify for a NASDAQ listing on a positive note, a listing that would be used to raise funds for the next year's operations. I expect that the loan issue would be solved by an extension of the terms of the loan in exchange for additional warrants to Ken Dart.

The reason I am no longer so sure that Resverlogix has struck a deal is that Don sounded much less confident in the NY presentation - and, more importantly, that there has been insider buying - both by senior management and more recently by a director from the board of directors. I am not sure this would be allowed if they had struck a deal with BP.

Anyway, I think the big thing at the AGM is going to be centered around a NASDAQ listing, possibly also a reverse split. (BTW a reverse split is the same as turning 5 one-dollar notes into 1 five-dollar note, you would never think this as anything important, but when it comes to shares, people sometimes think they are being shortchanged by reverse splits).

Best regard,

B.